Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
The new facility is expected to generate 500-600 new jobs in the region
The study found BIC/LEN to be statistically non-inferior to BIKTARVY, Gilead’s current standard-of-care therapy
The expansion includes a larger technical and service team and increased local procurement
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
At the trial’s pre-specified interim analysis, giredestrant achieved a hazard ratio of 0.70, marking a statistically significant improvement in invasive disease-free survival
The launch of the study was on the occasion of the International Day of Persons with Disabilities
Alport Syndrome is caused by genetic mutations affecting type IV collagen in the kidneys, ears, and eyes
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Subscribe To Our Newsletter & Stay Updated
